awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q49907440-E1545D91-73EC-43D1-963E-EC79CFA51CAC
Q49907440-E1545D91-73EC-43D1-963E-EC79CFA51CAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49907440-E1545D91-73EC-43D1-963E-EC79CFA51CAC
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma.
P2860
Q49907440-E1545D91-73EC-43D1-963E-EC79CFA51CAC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q49907440-E1545D91-73EC-43D1-963E-EC79CFA51CAC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a0ee5745fe10d1ae39774cc1d9249025393af572
P2860
Glutamatergic pathway targeting in melanoma: single-agent and combinatorial therapies.